Susceptibility of clinical isolates of Bordetella pertussis to chemicals

被引:0
|
作者
Uttlova, P. [1 ,2 ]
Urban, J. [1 ]
Melichercikova, V [1 ]
Zavadilova, J. [3 ]
Fabianova, K. [4 ]
机构
[1] Natl Inst Publ Hlth, Natl Reference Lab Disinfect & Sterilisat, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
[3] Natl Inst Publ Hlth, Natl Reference Lab Pertussis & Diphtheria, Prague, Czech Republic
[4] Natl Inst Publ Hlth, Dept Infect Dis Epidemiol, Prague, Czech Republic
来源
关键词
Bordetella pertussis; susceptibility; disinfectants; BACTERIAL-RESISTANCE; DISINFECTANTS; TRICLOSAN;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of study: To test clinical isolates of Bordetella pertussis from the National Reference Laboratory for Pertussis and Diphtheria for susceptibility to commonly available disinfectants. Another aim was to determine the concentration and exposure time for each chemical under real conditions of use and possibly to detect the emergence of resistance to disinfectants among 34 strains of B. pertussis referred to the National Reference Laboratory for Pertussis and Diphtheria in 2014 and 2015. Material and methods: A total of 34 clinical isolates of Bordetella pertussis were tested for susceptibility to chemical disinfectants by three different methods. The microsuspension method was used for the primary screening, and the tests were carried out without protein contamination. Further testing was conducted in accordance with standard EN 14885, where the test procedure consists of several steps. Step 1 involves quantitative suspension methods (Phase 2, Step 1), and step 2 uses methods designed for practice (Phase 2, Step 2). The quantitative suspension method modified according to EN 13727+A2 was used in step 1 to confirm bactericidal activity of the test products under the dirty conditions. In step 2, clinical isolates were tested using a quantitative carrier test method under the dirty conditions modified according to EN 14561. Based on this standard, the real conditions of product use are simulated. Four disinfectants differing in composition and intended use were tested. Results: Disinfectant No. 1 showed bactericidal activity at a concentration of 0.5% after 2 min of exposure in the case of immersion or at a concentration of 5% after 2 min of exposure when treated by wiping. Disinfectant No. 2 was active at a concentration of 0.1% after 2 min of exposure or at a concentration of 1% after 2 min of exposure, respectively. Disinfectant No. 3 did not show bactericidal activity even at a concentration of 100% after 5 min of exposure. Disinfectant No. 4 showed bactericidal activity at a concentration of 10% after 5 min of exposure or at a concentration of 30% after 2 min of exposure. Conclusions: None of the strains tested was resistant. Using the methods that simulate the real conditions of use of disinfectants Nos. 1 and 2, it was possible to determine the concentration and exposure time needed to achieve disinfection of surfaces under the dirty conditions. Disinfectants Nos. 3 and 4 are not primarily intended for the treatment of surfaces but for the treatment of the skin and mucous membranes. The results obtained with the latter two products are interesting but inconclusive as the real conditions of their use were not simulated accurately.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 50 条
  • [1] Antimicrobial susceptibility of Bordetella pertussis isolates in the state of Washington
    Galanakis, Emmanouil
    Englund, Janet A.
    Abe, Patrick
    Qin, Xuan
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (05) : 609 - 611
  • [2] Bordetella pertussis isolates, Finland
    Mäkinen, J
    Mertsola, J
    Mooi, FR
    Van Amersfoorth, S
    Arvilommi, H
    Viljanen, MK
    He, QS
    [J]. EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 183 - 184
  • [3] Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines
    Hegerle, Nicolas
    Guiso, Nicole
    [J]. EXPERT REVIEW OF VACCINES, 2014, 13 (09) : 1135 - 1146
  • [4] Biofilm forming potential and antimicrobial susceptibility of newly emerged Western Australian Bordetella pertussis clinical isolates
    Dorji, Dorji
    Graham, Ross M.
    Richmond, Peter
    Keil, Anthony
    Mukkur, Trilochan K.
    [J]. BIOFOULING, 2016, 32 (09) : 1141 - 1152
  • [5] HAND DISINFECTANTS AND THEIR ACTIVITY AGAINST CLINICAL ISOLATES OF BORDETELLA PERTUSSIS
    Uttlova, Petra
    Urban, Jan
    [J]. CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 30 (04) : 230 - 234
  • [6] Differential in vitro expression of the brkA gene in Bordetella pertussis an Bordetella parapertussis clinical isolates
    Stefanelli, Paola
    Sanguinetti, Maurizio
    Fazio, Cecilia
    Posteraro, Brunella
    Fadda, Giovanni
    Mastrantonio, Paola
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (09) : 3397 - 3400
  • [7] SUSCEPTIBILITY OF BORDETELLA PERTUSSIS TO AMPICILLIN
    NELSON, JD
    MATTECK, BM
    MCNABB, J
    [J]. JOURNAL OF PEDIATRICS, 1966, 68 (02): : 222 - +
  • [8] Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method
    Fry, N. K.
    Duncan, J.
    Vaghji, L.
    George, R. C.
    Harrison, T. G.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (09) : 1183 - 1185
  • [9] Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method
    N. K. Fry
    J. Duncan
    L. Vaghji
    R. C. George
    T. G. Harrison
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29 : 1183 - 1185
  • [10] Variation of Housekeeping Genes in Clinical Isolates and Vaccine Strains of Bordetella pertussis
    Fathi, Masoumeh
    Haghighi, Faezeh
    Shahcheraghi, Fereshteh
    Abbasi, Ebrahim
    Eshraghi, Seyed Saeed
    Ghourchian, Sedighe
    Zeraati, Hojjat
    Yaseri, Mehdi
    Douraghi, Masoumeh
    Shokri, Fazel
    [J]. CLINICAL LABORATORY, 2017, 63 (04) : 809 - 815